Loading…
Pliant Therapeutics, Inc. is projected to rise to $1.18 by 2027, a +5% move from its current price of $1.12. PLRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $1.10 | $1.12 | $1.14 | -0.01% |
| Jul 15 | $1.09 | $1.12 | $1.15 | -0.03% |
| Jul 16 | $1.08 | $1.12 | $1.16 | -0.04% |
| Jul 17 | $1.08 | $1.12 | $1.16 | -0.05% |
| Jul 18 | $1.07 | $1.12 | $1.17 | -0.06% |
| Jul 19 | $1.07 | $1.12 | $1.17 | -0.08% |
| Jul 20 | $1.07 | $1.12 | $1.17 | -0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.07 | $1.12 | $1.17 | -0.09% |
| Week 2 | $1.04 | $1.12 | $1.20 | -0.18% |
| Week 3 | $1.03 | $1.12 | $1.21 | -0.27% |
| Week 4 | $1.01 | $1.12 | $1.23 | -0.36% |
| Week 5 | $1.00 | $1.12 | $1.24 | -0.45% |
| Week 6 | $0.9896 | $1.11 | $1.25 | -0.53% |
| Week 7 | $0.9794 | $1.11 | $1.26 | -0.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing integrin-based therapeutics for the treatment of solid tumors. Its lead candidate PLN-101095 is an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for solid tumors.
The company was incorporated in 2015 and is headquartered in South San Francisco, California. It also develops a drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. The stock trades in the Healthcare sector under symbol PLRX.
PLRX is a healthcare stock with current price $1.16, a market cap of $71.83M, and a rank of 4134. The near-term technical picture shows a neutral stance, with RSI(14) at 50 and moving averages close to the price: SMA50 at $1.21 and SMA200 at $1.36. The 30-day range is $1.03 to $1.31, with near-term support at $1.13 and resistance at $1.26.
A major floor 9.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.9% away) — a key level to hold.
The nearest ceiling, 12.5% above — a clean break opens room to run.
A major ceiling 25.9% above — clearing it would confirm fresh momentum.
Key PLRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PLRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.14 | Sell | $1.14 | Sell |
| MA 10 | $1.14 | Sell | $1.14 | Sell |
| MA 20 | $1.15 | Sell | $1.15 | Sell |
| MA 50 | $1.18 | Sell | $1.18 | Sell |
| MA 100 | $1.23 | Sell | $1.23 | Sell |
| MA 200 | $1.33 | Sell | $1.64 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.74 | Neutral |
| Stoch RSI (14) | 35.36 | Neutral |
| CCI (20) | -107.78 | Sell |
| Williams %R (14) | -83.33 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -3.45 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 16.67 | Buy |
| TRIX (15) | -0.17 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 42.72 | Neutral |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 1.14 | Sell |
| ADX (14) | 11.49 | Neutral |
| ATR (14) | 0.02 | Info |
Near-term sentiment is NEUTRAL, with RSI(14) at 50. The stock trades near its moving-averages, with SMA50 at $1.21 and SMA200 at $1.36. The 30-day range is from $1.03 to $1.31, with support at $1.13 and resistance at $1.26.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.09 | $1.12 | $1.31 | 0% | Neutral | |
| $0.9658 | $1.18 | $1.51 | +5% | Neutral | |
| $0.9638 | $1.20 | $1.57 | +7% | Neutral | |
| $0.9952 | $1.26 | $1.68 | +12% | Neutral | |
| $1.10 | $1.41 | $1.93 | +26% | Bullish | |
| $1.25 | $1.63 | $2.25 | +45% | Bullish | |
| $1.40 | $1.83 | $2.57 | +64% | Bullish | |
| $1.42 | $1.88 | $2.68 | +68% | Bullish | |
| $1.42 | $1.90 | $2.73 | +69% | Bullish | |
| $1.46 | $1.97 | $2.87 | +76% | Bullish | |
| $2.17 | $3.05 | $4.65 | +172% | Bullish | |
| $3.43 | $5.18 | $8.47 | +363% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.09 | $1.12 | $1.33 | +0.00% |
| August 2026 | $0.9457 | $1.11 | $1.32 | -1.17% |
| September 2026 | $0.9413 | $1.11 | $1.33 | +0.01% |
| October 2026 | $0.9491 | $1.12 | $1.36 | +1.24% |
| November 2026 | $0.9269 | $1.10 | $1.34 | -2.00% |
| December 2026 | $0.9004 | $1.07 | $1.31 | -2.54% |
Click any year to see its month-by-month PLRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, PLRX could reach as high as $1.31, with a base case around $1.12 and support toward $1.09 — roughly 0% from $1.12. A consolidation phase looks the most probable path here.
Expect PLRX to range from $0.9658 to $1.51 through 2027. The $1.18 average target implies a +5% move from current prices. That is up +5% on the projected 2026 average. Price action looks broadly range-bound.
The PLRX price prediction for 2028 points to an average of $1.20 (low $0.9638, high $1.57) — a potential gain of +7% on today's $1.12. A consolidation phase looks the most probable path here.
In 2029, PLRX is projected to trade between $0.9952 and $1.68, averaging $1.26 — a potential gain of +12% from today's $1.12. That is up +5% on the projected 2028 average. Price action looks broadly range-bound.
Pliant Therapeutics, Inc.'s 2030 outlook centres on $1.41, within a $1.10 to $1.93 range. That is up +12% on the projected 2029 average. That marks a +26% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, PLRX could reach as high as $2.25, with a base case around $1.63 and support toward $1.25 — roughly +45% from $1.12. Momentum favours further upside here.
Expect PLRX to range from $1.40 to $2.57 through 2032. The $1.83 average target implies a +64% move from current prices. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The PLRX price prediction for 2033 points to an average of $1.88 (low $1.42, high $2.68) — a potential gain of +68% on today's $1.12. Momentum favours further upside here.
In 2034, PLRX is projected to trade between $1.42 and $2.73, averaging $1.90 — a potential gain of +69% from today's $1.12. That is up +1% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Pliant Therapeutics, Inc.'s 2035 outlook centres on $1.97, within a $1.46 to $2.87 range. That is up +4% on the projected 2034 average. That marks a +76% change versus current levels. Momentum favours further upside here.
By 2040, PLRX could reach as high as $4.65, with a base case around $3.05 and support toward $2.17 — roughly +172% from $1.12. Buyers look set to stay in control over this stretch.
Expect PLRX to range from $3.43 to $8.47 through 2050. The $5.18 average target implies a +363% move from current prices. That is up +70% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in PLRX today (≈ 892.857143 PLRX) could be worth
$4,626.27
+$3,626.27 (+363%) by 2050 · US Dollar
Based on the average projected PLRX price of $5.18 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PLRXwould be worth at today's price.
$1,000 invested in PLRX on Jul 10, 2025 (≈ 714.285726 PLRX) would be worth
$800
-$200 (-20.0%) today · 0.80× · US Dollar
Based on a PLRX entry price of $1.4 vs. today's $1.12.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.17 | $957.26 | -4.3% |
| 1 month ago | $1.16 | $965.52 | -3.4% |
| 3 months ago | $1.28 | $875 | -12.5% |
| 6 months ago | $1.33 | $842.11 | -15.8% |
| 1 year ago | $1.4 | $800 | -20.0% |
| All time (5.0y) ago | $24.73 | $45.29 | -95.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PLRX forecast.
Our base-case forecast reaches $2.20 around 2040.
Implied market cap at $2.20: $136.22M
The multi-year forecast shows a bullish trajectory beginning in 2030. In 2030 the average price is $1.60, with a min of $1.25 and a max of $2.18, delivering a ROI of 37.6% and a bullish sentiment. By 2040 the average is $3.51 (min $2.49, max $5.36) with a ROI of 202.6% and a bullish sentiment.
By 2050 the average reaches $6.36 (min $4.21, max $10.40) with a ROI of 448.4% and a bullish sentiment. Earlier years show gradual gains, with 2026 average $1.16, 2027 $1.27, 2028 $1.27, and 2029 $1.37, all reflecting NEUTRAL sentiment in those periods. These figures are estimates and not guarantees; they project a path toward notable upside in the outer horizon while acknowledging uncertainty and variability in outcomes.
Tap a question to reveal the answer.
2030 average price is $1.60 with a minimum of $1.25 and a maximum of $2.18, for a projected ROI of 37.6% and a BULLISH sentiment.
Forecasts show a path of potential gains, with 2030 avg $1.60 and 2050 avg $6.36, yielding up to 448.4% ROI. Current price is $1.16 and 2026–2029 years show gradual gains, but these are estimates and not guarantees.
Yes. The 2040 forecast lists a max price of $5.36, indicating the potential to surpass $5 in that year range.
Current price is $1.16 and market cap is $71.83M, with a rank of 4134.
Sentiment is NEUTRAL. RSI(14) is 50, with SMA50 at $1.21 and SMA200 at $1.36. The 30-day range is $1.03–$1.31, with support at $1.13 and resistance at $1.26.
Pliant Therapeutics, Inc. Community Discussion
0Share your Pliant Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.